The Hindu Business Line : Templeton Strategic buys 2.9 pc stake in Aurobindo Pharma

TEMPLETON Strategic Emerging Markets LDC has acquired 13,05,460 equity shares amounting to 2.9 per cent of the total paid-up capital of Aurobindo Pharma Ltd (APL).

The mode of acquisition of the shares was through the open market and was completed on a single day on April 30, 2004, Templeton Strategic informed the National Stock Exchange on Friday. The shareholding of Templeton Strategic Emerging Markets after this acquisition stands at 36,79,596 equity shares amounting to 7.9131 per cent of the total paid-up capital of APL.

The APL board had allotted one million equity shares and equal number of share warrants to Templeton Strategic in April 2002. In addition to Templeton Strategic, other major foreign institutional investors (FIIs) in APL are ABN Amro Funds and Copthall Mauritius Investment Ltd.

More Stories on : Pharmaceuticals | Mergers & Acquisitions

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Bharti, Reliance lead in mobile user base

Bangalore-bound, but still inside Intel

Post-poll, no major hike in petrol, diesel prices likely

Templeton Strategic buys 2.9 pc stake in Aurobindo Pharma

Polls shadow markets; Sensex down 87 points

Steel subsidy pact not acceptable, OECD told

Ministry exploring ways to encash FM cos' guarantees

Chemplast Sanmar duo wins Business Line Quiz